BAKER BROS. ADVISORS LP Q3 2022 Filing
Filed November 14, 2022
Portfolio Value
$15.3B
Holdings
115
Report Date
Q3 2022
Filing Type
13F-HR
All Holdings (115 positions)
| Stock | Value |
|---|---|
SGENUSDSeagen Inc. | $6.4B |
INCYIncyte Corporation | $2.4B |
ONCBeiGene, Ltd. | $1.6B |
ACADACADIA Pharmaceuticals Inc. | $685.9M |
BMRNBioMarin Pharmaceutical Inc. | $646.0M |
ASNDAscendis Pharma A/S | $501.1M |
GBTUSDGlobal Blood Therapeutics, Inc. | $254.2M |
BCRXBioCryst Pharmaceuticals, Inc. | $160.2M |
RYTMRhythm Pharmaceuticals, Inc. | $148.5M |
KODKodiak Sciences Inc. | $134.0M |
IMCRImmunocore Holdings plc | $118.3M |
ABCLAbCellera Biologics Inc. | $103.4M |
ARGXargenx SE | $98.9M |
MRTXEURMirati Therapeutics, Inc. | $98.5M |
MDGLMadrigal Pharmaceuticals, Inc. | $97.4M |
CCXIEURChemoCentryx, Inc. | $92.6M |
TVTXTravere Therapeutics, Inc. | $81.3M |
AKROAkero Therapeutics, Inc. | $80.6M |
TRDAEntrada Therapeutics, Inc. | $76.7M |
1K0IGM Biosciences, Inc. | $71.8M |
REPLReplimune Group, Inc. | $67.2M |
PRLDPrelude Therapeutics Inc. | $66.9M |
KYMRKymera Therapeutics, Inc. | $62.7M |
HZNPHorizon Therapeutics Public Ltd Co | $60.0M |
CERSCerus Corporation | $57.8M |
NRIXNurix Therapeutics, Inc. | $50.6M |
290AChinook Therapeutics, Inc. | $49.8M |
VERVVerve Therapeutics, Inc. | $48.7M |
IMTXImmatics N.V. | $44.2M |
—Forma Therapeutics Holdings, Inc. | $37.6M |
INSM 0.75 06/01/28Insmed Incorporated | $36.3M |
KNSAKiniksa Pharmaceuticals, Ltd. | $35.9M |
HRTXHeron Therapeutics, Inc. | $34.3M |
AVTEAerovate Therapeutics, Inc. | $32.8M |
TSVT*2seventy bio, Inc. | $30.0M |
KRYSKrystal Biotech, Inc. | $29.4M |
XENEXenon Pharmaceuticals Inc. | $27.1M |
—CinCor Pharma, Inc. | $26.5M |
—DBV Technologies S.A. | $25.9M |
IDYAIDEAYA Biosciences, Inc. | $24.9M |
DSGNDesign Therapeutics, Inc. | $24.0M |
VSTMVerastem, Inc. | $22.9M |
ALTAltimmune, Inc. | $22.6M |
NVTA1EURInvitae Corporation | $20.7M |
BMEABiomea Fusion, Inc. | $20.6M |
BCYCBicycle Therapeutics plc | $19.6M |
RAREUltragenyx Pharmaceutical Inc. | $19.5M |
TILInstil Bio, Inc. | $18.8M |
VERUEURVeru Inc. | $18.5M |
RLMDRelmada Therapeutics, Inc. | $18.3M |
ALKSAlkermes plc | $18.2M |
DNLIDenali Therapeutics Inc. | $18.1M |
OPTEYOpthea Limited | $16.7M |
—bluebird bio, Inc. | $15.8M |
CRNXCrinetics Pharmaceuticals, Inc. | $14.4M |
WHWKAadi Bioscience, Inc. | $14.0M |
1T7Tricida, Inc. | $13.8M |
—Affimed N.V. | $13.6M |
—DICE Therapeutics, Inc. | $11.9M |
ANABAnaptysBio, Inc. | $10.9M |
FGENEURFibroGen, Inc. | $10.6M |
ADAPYAdaptimmune Therapeutics plc | $10.6M |
—Zymeworks Inc. | $10.5M |
—POINT Biopharma Global Inc. | $9.0M |
TCRXTScan Therapeutics, Inc. | $8.5M |
—Invitae Corporation | $8.1M |
CBAYUSDCymaBay Therapeutics, Inc. | $7.6M |
VERAVera Therapeutics, Inc. | $7.1M |
PACBPacific Biosciences of California, Inc. | $6.5M |
FLGTFulgent Genetics, Inc. | $6.4M |
AMRNAmarin Corporation plc | $5.9M |
698Achilles Therapeutics plc | $5.9M |
VORVor Biopharma Inc. | $5.8M |
RETAEURReata Pharmaceuticals, Inc. | $5.6M |
BCELAtreca, Inc. | $5.5M |
NKTXNkarta, Inc. | $5.3M |
—Talis Biomedical Corporation | $5.2M |
KRON1USDKronos Bio, Inc. | $5.2M |
CYTCyteir Therapeutics, Inc. | $5.1M |
SRZNSurrozen, Inc. | $5.0M |
EWTXEdgewise Therapeutics, Inc. | $4.9M |
FATEFate Therapeutics, Inc. | $4.8M |
STOKStoke Therapeutics, Inc. | $4.7M |
RVMDRevolution Medicines, Inc. | $4.4M |
NTRANatera, Inc. | $4.4M |
ALLKGUSDAllakos Inc. | $4.3M |
CLDNEUREiger BioPharmaceuticals, Inc. | $4.1M |
PMVPPMV Pharmaceuticals, Inc. | $3.8M |
IPSCCentury Therapeutics, Inc. | $3.7M |
HOOKGBPHOOKIPA Pharma Inc. | $3.2M |
—Athira Pharma, Inc. | $3.1M |
MGNXMacroGenics, Inc. | $3.1M |
5E7iTeos Therapeutics, Inc. | $2.9M |
ATRAGBXAtara Biotherapeutics, Inc. | $2.8M |
TNGXTango Therapeutics, Inc. | $2.7M |
SNDXSyndax Pharmaceuticals, Inc. | $2.7M |
OTICEUROtonomy, Inc. | $2.5M |
—Neoleukin Therapeutics, Inc. | $2.4M |
ALGSAligos Therapeutics, Inc. | $2.3M |
ALECAlector, Inc. | $2.3M |
Page 1 of 2Next